TargetMol

Tianeptine sodium salt

Product Code:
 
TAR-T2402
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T2402-1mL1 mL * 10 mM (in DMSO)£95.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2402-10mg10mg£102.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2402-25mg25mg£112.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2402-50mg50mg£120.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2402-100mg100mg£144.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2402-200mg200mg£179.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Tianeptine sodium is a selective serotonin reuptake enhancer (SSRE), used to treat major depressive episodes.
CAS:
30123-17-2
Formula:
C21H24ClN2NaO4S
Molecular Weight:
458.93
Pathway:
Neuroscience; GPCR/G Protein
Purity:
0.9979
SMILES:
[Na+].CN1c2ccccc2C(NCCCCCCC([O-])=O)c2ccc(Cl)cc2S1(=O)=O
Target:
5-HT Receptor

References

1. Kim SJ, et al. Neuropharmacology, 2006, 50(7), 824-833. 2. Vouimba RM, et al. Stress, 2006, 9(1), 29-40. 3. Castanon N, et al. Psychopharmacology (Berl), 2001, 154(1), 50-60. 4. Kole MH, et al. Eur J Neurosci, 2002, 16(5), 807-816. 5. Lucassen PJ, et al. Biol Psychiatry, 2004, 55(8), 789-796.